By Hamza Faisal
Unitree, China's best-known humanoid robot maker, has reported a sharp rise in revenue in its first earnings result since its blockbuster stock market listing, but profit fell short of expectations as the company poured money into research. The results, published in a Shanghai Stock Exchange filing on Wednesday, offer the first hard test of a sector that has attracted enormous investor enthusiasm despite questions about when humanoid robots will find profitable, large-scale uses.
Third-quarter revenue rose 70% from a year earlier to 665 million yuan, about $100 million. Net profit attributable to shareholders fell 17.4% to 112.7 million yuan, roughly $16.9 million, well below analysts' forecast of 224 million yuan. The miss came even as sales surged, because Unitree more than doubled its research and development spending in the quarter.
Revenue surges, profit misses
For the first nine months of the year, the picture looked stronger. Revenue climbed 55.7% to 1.82 billion yuan, while net profit rose 270.5% to 386.7 million yuan. The company attributed the nine-month profit surge to higher gross profit and to a large one-time share-based payment expense booked in the prior-year period, which depressed the comparison base.
The third quarter tells a different story about the cost of staying ahead. Research and development spending jumped 249.6% to 127.0 million yuan, equal to 19.1% of quarterly revenue. That spending explains the profit fall despite the sales surge, and signals Unitree is prioritising technology investment over short-term earnings.
An R&D bet on embodied intelligence
Unitree said the research spending went into embodied-intelligence large models, computing capacity and expanding its research team. Embodied intelligence, the combination of AI models with physical robots that can perceive and act in the real world, is the central bet of China's humanoid industry. Companies argue that robots trained on vast amounts of physical data will eventually handle factory work, logistics and household tasks, but building those models requires heavy, sustained investment.
The filing did not say how Unitree plans to use the roughly 6 billion yuan, about $900 million, it raised in its initial public offering in August. That silence leaves investors to judge the company on its operating numbers alone for now, and the third-quarter figures show a company still spending like a research project even as it scales commercial sales.
Unitree remains one of the few profitable domestic robot firms in China, a distinction that matters in a sector where many rivals are still loss-making. Profitability is thin relative to the sector's valuations, and the miss will sharpen scrutiny of how quickly research spending converts into revenue.
A bellwether for China's robot boom
Investors are watching Unitree closely as a bellwether for future listings of Chinese humanoid robot makers, whose technology has not yet proved its commercial viability at scale. The sector has cooled in recent weeks amid a broader tech market rout, and Reuters reported last month that Chinese regulators are slowing down IPOs for humanoid robot firms amid stock volatility, examining whether soaring valuations and revenue tied to state-backed projects reflect genuine commercial demand.
Unitree's results capture that tension precisely: demand is growing fast, with revenue up 70%, but the path to durable profits runs through expensive research whose payoff is uncertain. For the next wave of robot makers hoping to list, Unitree's first earnings report sets an uncomfortable benchmark, strong sales growth paired with a profit miss and a research bill that more than tripled.



